BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21315421)

  • 1. Parafibromin expression is an independent prognostic factor for colorectal carcinomas.
    Zheng HC; Wei ZL; Xu XY; Nie XC; Yang X; Takahashi H; Takano Y
    Hum Pathol; 2011 Aug; 42(8):1089-102. PubMed ID: 21315421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
    Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
    Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
    Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F
    Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas.
    Zheng HC; Xu XY; Xing YN; Wei ZL; Takahashi H; Masuda S; Takano Y
    Hum Pathol; 2010 May; 41(5):724-36. PubMed ID: 20096920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of parafibromin expression on the phenotypes and relevant mechanisms in the DLD-1 colon carcinoma cell line.
    Zhao S; Sun HZ; Zhu ST; Lu H; Niu ZF; Guo WF; Takano Y; Zheng HC
    Asian Pac J Cancer Prev; 2013; 14(7):4249-54. PubMed ID: 23991985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
    Nakayama T; Ito M; Ohtsuru A; Naito S; Sekine I
    Mod Pathol; 2001 May; 14(5):415-22. PubMed ID: 11353051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.
    Xing YN; Yang X; Xu XY; Zheng Y; Xu HM; Takano Y; Zheng HC
    Hum Pathol; 2011 Jan; 42(1):25-35. PubMed ID: 21062663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
    Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy.
    Shen DF; Liu X; Yang XF; Fang L; Gao Y; Zhao S; Wu JC; Shi S; Li JJ; Zhao XX; Gou WF; Zheng HC
    Tumour Biol; 2016 Mar; 37(3):2909-24. PubMed ID: 26409451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
    Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
    Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of parafibromin expression in a subset of parathyroid adenomas.
    Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
    Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Virchows Arch; 2008 Feb; 452(2):147-55. PubMed ID: 18080135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro and vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target.
    Zheng HC; Liu JJ; Li J; Wu JC; Yang L; Zhao GF; Zhao X; Jiang HM; Huang KQ; Li ZJ
    Oncotarget; 2017 Apr; 8(14):23603-23612. PubMed ID: 28223542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between c-myc protein expression and phases of the cell cycle in human colorectal carcinomas.
    Sato H; Tsuchiya A; Abe R
    Fukushima J Med Sci; 1995 Dec; 41(2):111-23. PubMed ID: 8823991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
    Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parafibromin expression in breast cancer: a novel marker for prognostication?
    Selvarajan S; Sii LH; Lee A; Yip G; Bay BH; Tan MH; Teh BT; Tan PH
    J Clin Pathol; 2008 Jan; 61(1):64-7. PubMed ID: 17468290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.